Cyndeo Wealth Partners LLC Has $5.56 Million Position in Intuitive Surgical, Inc. $ISRG

Cyndeo Wealth Partners LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,227 shares of the medical equipment provider’s stock after acquiring an additional 514 shares during the period. Cyndeo Wealth Partners LLC’s holdings in Intuitive Surgical were worth $5,557,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of ISRG. Chilton Capital Management LLC grew its holdings in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. bought a new position in shares of Intuitive Surgical during the 1st quarter worth about $26,000. LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. TD Capital Management LLC boosted its position in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $443.76 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a market cap of $159.08 billion, a price-to-earnings ratio of 61.89, a PEG ratio of 4.71 and a beta of 1.61. The firm’s 50-day simple moving average is $459.75 and its 200 day simple moving average is $498.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter last year, the firm earned $1.78 EPS. The company’s quarterly revenue was up 21.4% compared to the same quarter last year. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday. BTIG Research reissued a “buy” rating and set a $571.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 1st. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 4th. Fourteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $589.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.